Xth Eurasian Hematology-Oncology Congress

http://www.ehog.net/

 

2019 SOHO Update on ALL: Ponatinib -Blinatumomab in Ph+, Ino / Blinatumomab + ChemoRx in Salvage and Frontline, Bcl2-Bclxl Inhibitors, and Blinatumomab SQ TIW

108 views
December 13, 2019
Comments 0
Login to view comments. Click here to Login